From Science to Start Up: Developing a Gene Therapy for a Rare Blood Disorder
After 20 years of research on gene therapy and the rare blood disease, Diamond–Blackfan Anemia, DBA, researcher Johan Flygare had reached a point where he and his colleagues had done everything they could in the lab. Even though they had proof of concept their gene therapy would work, engaging companies had been difficult. Then, in 2021, he received an e-mail. The message came from American entrep
https://www.stemcellcenter.lu.se/article/science-start-developing-gene-therapy-rare-blood-disorder - 2025-11-03
